Induction of reactive oxygen intermediates in human monocytes by tumour cells and their role in spontaneous monocyte cytotoxicity by Mytar, B et al.
Macrophages are prominent in the cellular infiltrates surrounding
the tumour and can constitute more than 50% of the total tumour
mass (Leek et al, 1996). Mononuclear cell infiltration is regarded
as a manifestation of the host response against the growing 
tumour (Zembala and Buckle, 1989). The anti-tumour effect of
macrophages may be due to their cytotoxic/cytostatic activity, in
which several toxic mediators including tumour necrosis factor a
(TNF-a), reactive nitrogen intermediates (RNI) and reactive
oxygen intermediates (ROI) are involved. The presence of TNF-
mRNA has been demonstrated in tumour infiltrating macrophages
(TIM), which is taken as evidence for the local production of this
and perhaps other cytokines with anti-tumour activities (Beissert
et al, 1989). In humans, there is no evidence for the local produc-
tion of oxygen radicals in the tumour bed, however, the role of
ROI in the anti-tumour response in humans has been indirectly
implicated by observations that myeloperoxidase-deficient indi-
viduals have an increased incidence of neoplasms (Lanza et al,
1987). The direct evidence for the importance of ROI in the killing
of tumour cells comes from the cell-free systems generating
hydrogen peroxide or superoxide anion (O2
– .) (Ioannidis and 
de Groot, 1993; Palomba et al, 1996). TIM from mouse mammary
carcinomas are able to produce ROI (Mantovani et al, 1992). An
increased production of ROI by monocytes was observed in
patients with cancer (Trulson et al, 1988, 1994), but the stimulus
responsible for their generation has not been established. In
contrast to murine macrophages, freshly isolated human mono-
cytes exhibit considerable spontaneous cytotoxicity towards
tumour cells (Davies and Edwards, 1992; Martin and Edwards,
1993), but its origins remain largely unclear. Davies and Edwards
(1992) demonstrated that cytotoxic factors were released by
monocytes cultured with K562 tumour cells, whereas monocytes
and tumour cells cultured alone released factor(s) which promoted
K562 cells growth. Furthermore, inhibitors of ROI added to K562
cells enhanced their growth. This led us to explore the possibility
that spontaneous cytotoxic activity of monocytes may, at least
partly, be due to ROI production induced by tumour cells in the co-
culture.
The present study shows that stimulation of monocytes with
tumour, but not untransformed, cells induces the production of
ROI, as determined by the generation of chemiluminescence (CL)
and O2
– .. The CL response was associated with O2
– . and OH
.
produc-
tion and was dependent on the presence of myeloperoxidase. This
study also demonstrates that O2
– ., hydrogen peroxide, OH
.
and
probably hypohalite(s) are involved in monocyte-mediated sponta-
neous cytotoxicity. This may imply that this ‘spontaneous’ cyto-
toxicity is probably an inducible event that occurs after contact of
monocytes with tumour cells.
MATERIALS AND METHODS
Isolation of cell populations
Human peripheral blood mononuclear cells were isolated from
EDTA–blood of healthy donors on a standard Ficoll/Isopaque
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/(Pharmacia, Uppsala, Sweden) density gradient centrifugation.
Monocytes were separated from mononuclear cells by counterflow
centrifugal elutriation with a JE –5.0 elutriation system equipped
with a 5-ml Sanderson separation chamber (Beckman, Palo Alto,
CA, USA) as previously described (Zembala et al, 1994a).
Isolated monocytes were 90–96% pure, as judged by flow cytom-
etry analysis (FACScanV, Becton-Dickinson, Mountain View, CA,
USA), using anti-CD14 (Leu-M3; Becton-Dickinson) monoclonal
antibody (Zembala et al, 1994a) and contained 2–4% NK cells, as
judged by staining with anti-CD56 monoclonal antibody (Dako,
Glostrup, Denmark). The cells were suspended in culture medium
RPMI-1640 (Biochrom, Berlin, Germany) with gentamycin 
(25 mg ml–1, Biochrom), glutamine (2 mM, Gibco, Paisley, UK)
and 10% fetal calf serum (FCS) (Biochrom).
Cell lines
The following human cell lines were used: HPC-4 (human pancre-
atic adenocarcinoma) (Siedlar et al, 1995), CaOV (ovarian carci-
noma), normal human skin fibroblasts, peritoneal mesothelial cells
(obtained in our laboratory), and established cell lines DeTa (colon
carcinoma), Hu 1703 (transitional cell bladder carcinoma), BC3726
(v-raf transfected normal bladder epithelium) and HCV 29 (normal
uroepithelium) (Zembala et al, 1994a). Hep G2 (hepatocellular
carcinoma) and Caco-2 (colon adenocarcinoma) were obtained
from Professor V Colizzi (II Universitá di Roma, Italy). Cell lines
were cultured by biweekly passages in RPMI-1640 with 5% FCS.
All cell lines were regularly tested for Mycoplasma sp. contamina-
tion using standard PPLO medium (Difco, Detroit, MI, USA).
Chemiluminescence
CL was used to detect activated oxygen species (Ernst et al, 1984).
Various tumour cells/monocytes ratios were used to establish
conditions for optimal CL response. As a result, 1 ´ 105 monocytes
and 5 ´ 105 tumour cells were resuspended in 100 ml of culture
medium and added to the vials (Berthold, Vienna, Austria). Then,
300 ml of 2 mM luminol (5-amino-2,3-dihydro-1,4-phtalazine-
dione, Sigma, St. Louis, MO, USA) in Krebs-Ringer buffer with
Mg2+ and Ca2+ was added. The vials were placed in the measuring
chambers of a Multi-Biolumat (Berthold), kept at 37°C and the CL
response was continuously recorded. The results were calculated
as integrals (cumulative counts, cc) of the response recorded
during 300 min. Data were expressed as the percentage of control
response or CL index, calculated as:
cumulative counts of tumour-stimulated monocytes
CL index = 
cumulative counts of unstimulated monocytes
In some experiments, phorbol myristate acetate (PMA) (100 ng ml–1,
Sigma) was added to monocytes or tumour cell suspension and
the CL response was recorded.
Measurement of O2
– . production
Superoxide production was determined by the cytochrome c reduc-
tion assay as described by Pick and Mizel (1981). Briefly, mono-
cytes (1 ´ 105 per well) and tumour cells (1 ´ 104–3 ´ 105 per well)
were resuspended in 160 mM solution of ferricytochrome c (Sigma)
in phenol-red-free Hanks’ balanced salt solution (HBSS), and
plated in 96-well flat bottom tissue culture plates (Nunc, Roskilde,
Denmark) in a final volume of 100 ml per well. Wells supplemented
with 300 U ml–1 of superoxide dismutase (SOD) (Sigma) were used
as blanks. Cytochrome c reduction was measured after 2 h of
incubation at 550 nm in an Elisa reader (Labsystems Multiscan
Plus, Labsystems, Finland) using a 450-nm reference filter (Martin
and Edwards, 1993). Results were expressed as nM per 1 ´ 105 cells
per 2 h.
Determination of hydrogen peroxide production
Hydrogen peroxide detection was based on the horseradish perox-
idase-dependent oxidation of phenol red, as described by Pick and
Mizel (1981). Briefly, cells were washed and resuspended in assay
solution containing 0.56 mM of phenol red (Sigma) and 20 U ml–1
horseradish peroxidase (Sigma) in phenol-red-free HBSS, and
seeded in tissue culture plates in a final volume of 100 ml per well.
After incubation for 2 h, the reaction was stopped by the addition
of 10 ml of 1 N sodium hydroxide per well and absorbance was
read at 600 nm. Wells with sodium hydroxide added at the begin-
ning of testing were used as blanks. Results were expressed as nM
per 1 ´ 105 cells per 2 h.
Flow cytometry and cell sorting
Monocytes (2 ´ 106) were stimulated with HPC-4 cells (5 ´ 106)
for 40 min at 37°C. After washing, the cells were stained with anti-
CD14 monoclonal antibody (Becton-Dickinson) for 20 min at
4°C. Then, cells were washed and resuspended in 5 ml of
phosphate-buffered saline (PBS). Cell sorting was performed with
FACS Vantage Cytometer (Becton-Dickinson) equipped with a
Power Macintosh 7600/120 computer using a Cell Quest v. 3.0
software. The ion laser Innova Enterprice II (Coherent, Santa
Clara, CA, USA) operating at 488 nm was used as a light source.
After setting CD14+ (monocytes) and CD14– (tumour cells) gating,
sorting was performed using a 70 mm nozzle tip with a drop drive
frequency of 25 kHz, three drops envelopes and ‘normal-R’ sort
mode. Sorted cells were collected into water-cooled (constant
temperature circulator, Neslab Instruments, Portsmouth, NH,
USA) polystyrene Falcon 2057 tubes (Becton-Dickinson),
precoated with FCS to avoid plastic charging and cell attachment
to the well. The purity of sorted cells was checked by flow
cytometry and it exceeded 95%.
Inhibitors of ROI production
The following blockers and scavengers of oxygen-free radicals 
(all from Sigma) were used at the indicated concentrations: super-
oxide dismutase (SOD, 100–600 U ml–1), catalase (CAT, 100–
5000 U ml–1), dimethyl sulphoxide (DMSO, 50–200 mM), defer-
oxamine mesylate (25–200 mM) and the inhibitor of myeloper-
oxidase 4-aminobenzoic acid hydrazide (ABAH, 50–150 mM).
Cytotoxicity assay
To obtain a significant cytotoxicity, monocytes were cultured 
with tumour cells at 1:0.4 ratio (Davies and Edwards, 1992).
Monocytes (5 ´ 104 per well), HPC-4 (2 ´ 104 per well) or their
mixtures were cultured for 20 h in the presence or absence of ROI
inhibitors or scavengers. Then, the culture medium was removed
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yl]-2,5-diphenyltetrazolium bromide, Sigma) dye solution was
added. Cell proliferation was assessed by reduction of MTT, as
previously described (Zembala et al, 1993; see also Hruby and
Beck, 1997). Percentage of cytotoxicity was calculated according
to the formula previously described (Hruby and Beck, 1997):
OD (monocytes + tumour cells) – OD (monocytes alone)
(1 – ) ´ 100
OD (tumour cells alone)
The effect of inhibitors on tumour cell survival was calculated as:
OD (tumour cells + inhibitor)
´ 100
OD (tumour cells alone) 
Statistical analysis
Significance analysis was performed using an unpaired Student’s
t-test. P-values < 0.05 were considered significant.
RESULTS
Induction of chemiluminescent response of human
monocytes by tumour cells
Monocytes were incubated with various tumour cells in the presence
of luminol, and the CL was recorded in a chemiluminometer. Figure
1A shows that monocytes incubated with cancer cells (HPC-4 or
DeTa) gave rise to the CL response, which reached a peak around
100–120 min, whereas monocytes kept in the medium yielded negli-
gible response. The addition of normal human uroepithelial cells
induced low level of CL. The response to tumour cells was much
slower than that seen after stimulation of monocytes with PMA
(Figure 1B), which peaked at 3–8 min, whereas during the first 
30 min monocytes stimulated with HPC-4 cells generated little CL.
Also, no significant CL was recorded when unstimulated and PMA-
stimulated tumour cells alone were used. Tumour cell lines differed
in their ability to evoke CL response. As shown in Table 1, a strong
response was induced by HPC-4, DeTa and Hep G2 cell lines. Other
cancer cells, Caco-2 and Hu 1703, elicited a moderate CL response,
whereas BC 3726 and CaOV induced a weak response. In contrast,
normal uroepithelial cells, peritoneal mesothelial cells or fibroblasts
(Table 1) did not stimulate significant CL. It was concluded that the
CL response of monocytes was the result of their direct interaction
with tumour cells, and that the response was different, but character-
istic, for the given cell line used.
Identification of cells responsible for CL generation
Because, potentially, both monocytes and cancer cells can produce
ROI, attempts were made to establish which cell type was respon-
sible for the CL response. Monocytes were stimulated with tumour
cells for 40 min, stained with anti-CD14 monoclonal antibody and
sorted out into CD14+ and CD14– populations. As control, unstim-
ulated monocytes were also sorted (‘dummy sorting’). These
procedures were timed in such a way to measure CL around the
peak of response. Table 2 shows that CD14+ cells that were in
contact with tumour cells gave a significantly higher CL response
than ‘dummy sorted’ CD14+ cells. CD14– cells showed a back-
ground CL. This clearly indicates that monocytes and not tumour
cells are the source of luminol-dependent CL.
Oxygen radicals in monocyte–tumour cell interactions 739
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Figure 1 The kinetics of the CL response of monocytes stimulated with
tumour cells. (A) Monocytes (1 ´ 105) were mixed with tumour cells (5 ´ 105)
HPC-4 (pancreatic carcinoma), DeTa (colon carcinoma) and normal
uroepithelial cells (HCV 29). After addition of luminol, CL was recorded over
300 min. (B) Monocytes were stimulated with PMA (1 hg ml–1) or HPC-4 cells
and CL recorded during 30 min. Unstimulated or PMA-stimulated HPC-4 cells
were also used. Results calculated as integrals and expressed in cc
(cumulative counts) are also indicated. A typical experiment, one of four, is
shown
Table 1 Ohemiluminescent response of monocytes stimulated with different
cell lines
Cell line CL index Range Number of
(mean ± s.d.) experiments
HPC-4 26.5 ± 17.5 9.0–58.0 10
Hep G2 25.3 ± 6.7 20.7–33.0 4
DeTa 14.1 ± 9.7 4.7–32.5 7
Caco-2 7.2 ± 5.7 2.0–5.3 4
Hu 1703 6.4 ± 3.5 3.8–10.4 3
BC 3726 4.2 ± 3.1 1.3–7.6 3
CaOV 4.1 ± 0.4 3.7–4.5 2
HCV 29 2.7 ± 1.0 1.4–4.1 5
Mesothelial cells 2.8 ± 0.2 2.8–3.1 2
Skin fibroblasts 2.6 ± 0.6 2.0–3.3 4
Monocytes (1 ´ 105 cells in 50 ml of culture medium) were stimulated with
tumour cells (5 ´ 105 cells in 50 ml of culture medium) in Krebs-Ringer buffer
with 2 mM luminol, and chemiluminescence (CL) was recorded during 
300 min. The data were expressed as index of CL, as described in Materials
and methods.The type(s) of free radical(s) generated by monocytes
stimulated with tumour cells
To establish which type of ROI was associated with generation of
CL by monocytes, the blockers or scavengers of free oxygen radi-
cals were used. SOD, which dismutates O2
– . to hydrogen peroxide,
deferoxamine, which prevents H
.
O formation, and DMSO, scav-
enger of OH
.
, diminished CL response of monocytes stimulated
with HPC-4 cells (Figure 2). This indicates that mainly O2
– . and
OH
.
were detected by luminol-dependent CL. Surprisingly, cata-
lase, which decomposes hydrogen peroxide to water and oxygen,
had no effect on CL generation, indicating that hydrogen peroxide
was not a major type of ROI evoking CL. Also, no synergistic
effect of SOD and catalase was observed (data not shown). The
CL response was myeloperoxidase-dependent because it was
markedly inhibited by ABAH. This indirectly indicated that
luminol-enhanced CL of monocytes stimulated with tumour cells
is dependent on O2
– . and OH
.
production and the presence of
myeloperoxidase.
Demonstration of O2 - ., but not hydrogen peroxide,
production by monocytes stimulated with tumour cells 
The cytochrome c reduction test was used to measure the level of
O2
– . production in the culture of monocytes with tumour cells
within 30–180 min. Addition of tumour cells at a low ratio
(1:0.1–1.0; monocytes:tumour cells respectively) increased O2
– .
production above the background level (release of O2
– . by
unstimulated monocytes) (Figure 3), whereas the admixure of
higher numbers of HPC-4 resulted in a decreased response. HCV
29 cells, incapable of stimulating CL in monocytes (Figure 1,
Table 1), were used as control.
When monocytes were cultured with tumour cells for 40 min
and then sorted into CD14+ and CD14– populations, it was
observed that the highest amount of O2
– . was produced by CD14+
cells (3.3 nM ± 0.08 per 1 ´ 105 cells, mean of three different
experiments), whereas CD14– cells generated 1.06 nM and
‘dummy sorted’ CD14+ cells – 0.90 nM of O2
– .. In these experi-
ments, the mean level of O2
– . found in the co-culture was 1.44 nM.
The production of O2
– . by CD14– cells was probably connected with
the presence of small numbers of contaminating monocytes in this
population because HPC-4 cells alone, unstimulated or stimulated
with PMA (Figure 1B), LPS or fMLP (data not shown) did not
produce O2
– .. This again clearly points to CD14+ cells as the source
of O2
– . in the co-culture. In contrast, hydrogen peroxide was sponta-
neously produced by both monocytes and, even more, by tumour
cells. The level of hydrogen peroxide was not increased in co-
cultures (data not shown), in keeping with the absence of catalase
effect on the generation of CL by monocytes.
The effect of ROI scavengers on the inhibition of
tumour cell growth by monocytes
Freshly isolated human monocytes exhibit considerable cytotoxi-
city towards tumour cells. To assess a possible role of ROI in this
phenomenon, several ROI inhibitors were added to monocytes
cultured with HPC-4 tumour cells at the ratio 1:0.4. Under these
conditions, cytotoxicity, as assessed by the MTT test, in untreated
cultures was approximately 33%. It was significantly lower when
cells were treated with SOD, catalase and deferoxamine (Figure
4A). Also, ABAH diminished cytotoxicity. These inhibitors had
no effect on the proliferation of tumour cells cultured alone
(Figure 4B). This implies that hydrogen peroxide, O2
– . and OH
.
were involved in monocyte-mediated cytocidal activity.
DISCUSSION
The generation of ROI is thought to be one of the mechanisms
responsible for the anti-tumour effect of activated macrophages
(Ding et al, 1988; Jaattela and Wissing, 1993). It is also proposed
that the cytotoxic effect of TNF produced by monocytes is due to
the generation of ROI within target cells, which in turn activate
740 B Mytar et al
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Table 2 Chemiluminescence of monocytes (MO) sorted after contact with
tumour cells
Cells Integrals (cc)
MO, medium/unsorted 0.90 ´ 107
MO, medium/sorted CD14+ 0.75 ´ 107
CD14+ 7.49 ´ 107
MO, tumour cells/sorted CD14– 0.08 ´ 107
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Figure 2 Effect of ROI inhibitors on CL response of monocytes stimulated
with HPC-4 cells. SOD, catalase (CAT), deferoxamine (DEF), dimethyl
sulphoxide (DMSO) and ABAH were added to the mixture of monocytes and
HPC-4 cells. The results are expressed as the percentage of control
response of monocytes and HPC-4 cells without inhibitors. Means ± s.e. of
six different experiments are shown
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Figure 3 Generation of O2
– . release by monocytes (1 ´ 105 per well)
stimulated with different numbers of cancer (HPC-4) or normal uroepithelial
(HCV 29) cells. The level of O2
– . was determined after 2 h of incubation. Data,
based on four experiments, are expressed as nM per 2 h (means ± s.e.)pre-existing toxic mediators, e.g. proteases (Wong and Goeddel,
1989). There is also direct evidence that generation of O2
– . and
hydrogen peroxide in cell-free systems causes tumour cell killing
(Ioannidis and de Groot, 1993; Palomba et al, 1996). In humans,
there is indirect evidence that spontaneous cytotoxicity of mono-
cytes towards tumour cells may be associated with their ability to
produce ROI (Davies and Edwards, 1992; Martin and Edwards,
1993). Although an altered production of ROI by monocytes of
cancer patients has been observed (Trulson et al, 1988, 1994; Hara
et al, 1991), it is unclear which cells, and how, are stimulated for
ROI production.
The present studies addressed the question of whether mono-
cytes can be directly activated by tumour cells for ROI generation.
We are aware of only one report on the ability of K562 (chronic
myelogenous leukaemia) cells to stimulate peripheral blood
mononuclear cells for a CL response (Ernst et al, 1984). In this
report, monocytes were indirectly implicated as a source of 
CL, because phagocyte-depleted mononuclear cells were poor
producers. Our study clearly demonstrates that monocytes and not
tumour cells are the source of CL because CD14+, but not CD14–,
cells sorted out from the co-culture produced CL and released O2
– ..
The role of natural killer (NK) cells in the tumour cell-induced CL
response is unlikely because contamination of elutriated mono-
cytes with CD56+ cells is low, approximately only 2% CD14+ cells
show expression of CD56 (Rothe et al, 1996), and, finally, cell
populations highly enriched for NK activity do not respond in
target cell- and latex-induced CL (Ernst et al, 1984). Tumour cell-
induced CL response peaked around 2 h. These kinetics are
distinct from the rapid CL response seen after the activation of
monocytes with PMA (Figure 1B), lipoplysaccharide (LPS), latex
or zymosan, which lasts for 1–15 min (Trulson et al, 1988; Martin
and Edwards, 1993). Monocytes responded poorly to normal cells,
such as skin fibroblasts, uroepithelial and mesothelial cells,
compared with cancer cells. This may suggest that monocytes are
able to discriminate between transformed and normal cells. This is
in keeping with previous findings regarding the ability of mono-
cytes to release TNF and nitric oxide after stimulation with cancer,
but not untransformed, cells (Zembala et al, 1994a, b; Hasday et
al, 1990), and other observations on the capacity of activated
monocytes to lyse tumour, but not non-neoplastic, cells (Galligioni
et al, 1993). The molecular mechanism(s) by which monocytes can
distinguish cancer cells remains largely unknown, but the role of
phosphatidylserine (Utsugi et al, 1991) or hyaluronic acid (Pericle
et al, 1996) on tumour cells and CD44 determinants on monocytes
(Zembala et al, 1994b) have been implicated.
Why various tumour cells possess different capacities to induce
the CL response is unclear. Distinct surface structures of tumour
cells were found to be responsible for monocyte activation for
TNF production (Jänicke and Männel, 1990), but their molecular
structure has not been identified. Our preliminary observations
indicate that the presence of some adhesion molecules, including
CD44, and expression of hyaluronic acid on tumour cells, which is
known to vary considerably (van Muijen et al, 1995), may be
important.
CL is commonly used for the detection of ROI production.
However, there is no agreement on the type(s) of the oxygen
species responsible for generation of CL. Hydrogen peroxide, O2
– .,
1O2 (singlet oxygen) or OH
.
is generated during oxidative burst.
The decrease of tumour cell-induced CL after treatment with
deferoxamine or DMSO points to the role of OH
.
. In the present
system, CL was dependent on the presence of myeloperoxidase, as
shown by the inhibitory effect of ABAH. The inhibition of CL by
SOD indicated that also O2
– . is involved. Hydrogen peroxide, O2
– .,
and myeloperoxidase are implicated in CL generated by mono-
cytes stimulated with PMA and fMLP (McNally and Bell, 1996).
However, in our hands, CL induced by tumour cells was not
dependent on hydrogen peroxide generation because catalase had
no effect. Hence, tumour cell-induced CL response of monocytes
may be distinct from that induced by PMA or fMLP because of
different kinetics and range of oxygen species generated.
The involvement of O2
– . in the CL response was proven by a
direct demonstration of O2
– . production by monocytes stimulated
with cancer but not normal epithelial cells. Surprisingly, this
production occurred after stimulation of monocytes with rather
low numbers of tumour cells. The increased proportion of the latter
resulted in a smaller O2
– . release, which can be due to a negative
(inhibitory or inactivating) influence of tumour cells. It is known
that cancer cells may produce several factors that inactivate toxic
mediators, including SOD (Sun et al, 1989). Transforming growth
factor b (TGF-b), produced by tumour cells, may also be respon-
sible for the inhibition of O2
– . release because it blocks signalling
pathways, including protein tyrosine kinase (Pazdrak et al, 1995)
which is involved in signal transduction for ROI generation (Mytar
et al, 1998). Studies are underway to define inhibitory factors of
tumour cells which may down-regulate the response of monocytes.
In contrast to murine macrophages, freshly isolated human
blood monocytes exhibit considerable spontaneous cytotoxicity
towards tumour cells (Davies and Edwards, 1992), and there is
indirect evidence suggesting that ROI may be involved (Martin
Oxygen radicals in monocyte–tumour cell interactions 741
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Figure 4 Effect of ROI inhibitors on the growth of HPC-4 cells cultured with
or without monocytes. SOD (300 U ml–1), catalase (CAT, 500 U ml–1),
deferoxamine (DEF, 100 mM) and ABAH (100 mM) were added to co-cultures
of monocytes (5 ´ 104 per well) and HPC-4 cells (2 ´ 104 per well) (A), or to
HPC-4 cells cultured alone (B). After 24 h of incubation, MTT was added for
a further 2 h as described in Materials and methods. The results are
expressed as the percentage of growth inhibition of tumour cells by
monocytes (A) or tumour cell survival (B). The data represent the mean
values of three independent experiments ± s.e.and Edwards, 1993). On the basis of our study, it appears that this
‘spontaneous’ cytotoxicity of monocytes may in fact be due to
induction of production of several toxic molecules after contact
with tumour cells. As a result, generation of TNF (Hasday et al,
1990; Zembala et al, 1994b), RNI (Zembala et al, 1994a) and ROI
(this study) may be initiated and be responsible for the inhibition
of proliferation and/or destruction of tumour cells by previously
non-activated monocytes. The present study indicates that O2
– .,
hydrogen peroxide and OH
.
are involved in monocyte-mediated
cytotoxicity towards tumour cells. This conclusion is based on the
effect of specific ROI inhibitors. Because these inhibitors had no
effect on proliferation of tumour cells in the absence of mono-
cytes, it is likely that they down-regulated ROI production by
monocytes. The effect of catalase, the specific scavenger of
hydrogen peroxide, is somewhat confusing. Because highly toxic
hypohalites and OH
.
are generated from hydrogen peroxide (King
et al, 1997), the question arises whether inhibitory action of
catalase on the cytocidal activity of monocytes may be due to
decreased generation of these toxic molecules. The role of hypo-
halites may be supported by the inhibitory effect of ABAH, which
by blocking myeloperoxidase activity prevents their generation. It
remains unclear whether all above radicals are effector molecules
or whether at least some of them (O2
– ., hydrogen peroxide) act
mainly as precursors of other toxic intermediates.
The ability of various tumour cell lines to evoke a CL response
of monocytes may perhaps explain why in different systems cyto-
toxicity of monocytes was found to be ROI-dependent or ROI-
independent (Nakabo and Pabst, 1997). The involvement of 
ROI in the cytotoxic effect of Bacille Calmette-Guérin (BCG)- or
PMA-activated murine macrophages (Nathan et al, 1979; Nathan
and Cohn, 1980) and LPS- or PMA-activated human monocytes
(Klassen and Sagone, 1980; Mavier and Edgington, 1984; Martin
and Edwards, 1993; McLachlan et al, 1995) is well established.
The present data suggest that contact with tumour cells may acti-
vate cytocidal capacity of monocytes and generation of ROI.
Hence, ‘spontaneous’ monocyte cytotoxicity may, in fact, be an
inducible event. The question arises whether TIM can also be
stimulated by cancer cells for generation of ROI in the tumour bed.
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